Skip to main content
. 2019 Jan 7;6(1):1–9. doi: 10.1007/s40801-018-0146-9

Fig. 1.

Fig. 1

a Rheumatologist-reported reasons for discontinuing the treatment that directly preceded secukinumab initiation in patients with AS and b rheumatologist-reported reasons for secukinumab prescription in patients with AS (N = 78). AS ankylosing spondylitis